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Infection of humans with the West Nile flavivirus principally occurs via tick and mosquito bites. Here, we document the expression of
antigen processing and presentation molecules in West Nile virus (WNV)-infected human skin fibroblast (HFF) cells. Using a new
Flavivirus-specific antibody, 4G4, we have analyzed cell surface human leukocyte antigen (HLA) expression on virus-infected cells at a
single cell level. Using this approach, we show that West Nile Virus infection alters surface HLA expression on both infected HFF and
neighboring uninfected HFF cells. Interestingly, increased surface HLA evident on infected HFF cultures is almost entirely due to virus-
induced interferon (IFN)a/h because IFNa/h-neutralizing antibodies completely prevent increased surface HLA expression. In contrast, RT-
PCR analysis indicates that WNV infection results in increased mRNAs for HLA-A, -B, and -C genes, and HLA-associated molecules low
molecular weight polypeptide-2 (LMP-2) and transporter associated with antigen presentation-1 (TAP-1), but induction of these mRNAs is
not diminished in HFF cells cultured with IFNa/h-neutralizing antibodies. Taken together, these data support the idea that that both cytokine-
dependent and cytokine-independent mechanisms account for WNV-induced HLA expression in human skin fibroblasts.
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Introduction nese encephalitis virus, tick-borne encephalitis virus, andFlaviviruses are small single-stranded RNA viruses trans-
mitted via an arthropod vector, usually ticks and mosqui-
toes, to a variety of animal hosts (Monath and Heinz, 1996;
Rice, 1996). Flaviviruses include important human patho-
gens such as West Nile virus (WNV), the dengue viruses,
Yellow fever virus, Murray Valley encephalitis virus, Japa-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.03.036
Abbreviations: E, envelope; HLA, human leukocyte antigen; IF,
immunofluorescence; Ig, immunoglobulin; IHC, immunohistochemistry;
IFN, interferon; LMP-2, low molecular weight polypeptide-2; MHC, major
histocompatibility complex; moi, multiplicity of infection; NS1, nonstruc-
tural protein-1; pi, postinfection; TAP1, transporter associated with antigen
presentation-1; TNFa, tumor necrosis factor-a; WNV, West Nile virus.
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E-mail address: Lisa_Sedger@wmi.usyd.edu.au (L.M. Sedger).numerous viruses of veterinary significance (Monath and
Heinz, 1996; Rice, 1996). These viruses are all capable of
causing significant disease in their hosts, and being neuro-
tropic, many flaviviruses cause meningoencephalitis in
humans with frequent lethality in immunocompromised
individuals (Monath and Heinz, 1996).
Historically, human WNV infection has been geograph-
ically restricted to Africa and Asia, but it is currently
emerging as a significant pathogen in the USA and Europe
(Crook et al., 2002; Monath and Heinz, 1996; Murgue et al.,
2002; O’Leary et al., 2002). For example, in the USA, in
2001 there were 66 reported cases of human WNV disease
with 9 (13.6%) deaths (O’Leary et al., 2002), by October
2002, there were a total of 3399 human cases with 193
(5.6%) deaths (CDC update, 2002; WHO, 2002), and by
September 2003, an additional 1856 human cases were
reported with 37 (2%) fatalities (ProMed-mail, 2003). Exam-
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Romania (1996), where approximately 440 confirmed hu-
man cases occurred with 17 fatalities (3.8%), and smaller
outbreaks were reported between 1997 and 2000 with a total
of 33 confirmed human cases and 4 deaths (12%); Italy
(1998), where 6 of 14 infected horses died; Russia (1999),
where an estimated 480 human cases were reported with 40
fatalities (8.3%); and France (2000), where more than 250
laboratory confirmed equine infections were reported, 76 of
these presenting with neurological disorders, and 21 deaths.
Interestingly, no human WNV cases were reported in the
France 2000 outbreak, despite serological evidence that
infection had occurred (Murgue et al., 2001, 2002). West
Nile virus also appears to have spread to the United King-
dom (UK), with either the virus itself or antibodies to the
virus being detectable in more than 20 species of birds in the
UK in 2003. However, as in the 2000 French outbreak, no
human UK cases have been reported (Buckley et al., 2003).
The spread of WNV and its mortality rate have provoked
renewed study into how WNV interacts with and evades the
host organism’s immune system (for review, see (Diamond,
2003). This has greatly facilitated the recent development of
protective anti-flavivirus vaccines, which have broad poten-
tial use in humans and agriculturally important animals (Hall
et al., 2003; Pletnev et al., 2002).
It has long been demonstrated that flavivirus infection
induces increased surface expression of major histocompat-
ibility complex class I (MHC-I) molecules or analogous
human leukocyte antigen proteins (HLA) (for reviews, see
(Kesson et al., 2002; King and Kesson, 2003; Lobigs et al.,
1996, 2003). Other surface immune recognition molecules
that are upregulated by flaviviruses are MHC-II, intracellu-
lar adhesion molecule-1, E-selectin, and vascular cell adhe-
sion molecule-1 (Kesson et al., 2002; King and Kesson,
1988; King et al., 1989; Shen et al., 1995, 1997). However,
very few studies have examined flavivirus replication in
human cells that are physiologically relevant to in vivo
infection. Here, we have studied West Nile virus infection in
an in vitro model of primary human skin fibroblasts (HFF),
because initial virus infection principally occurs in extra-
vascular tissues of the host after inoculation via a virus-
bearing mosquito (Monath and Heinz, 1996). We have
generated a fluorescein-labelled, flavivirus-specific mono-
clonal antibody probe for the detection of WNV proteins at
a single cell level, and used this reagent, together with RT-
PCR analysis, to study the mechanism(s) of WNV-induced
alterations in HLA and class I-associated molecules.Fig. 1. Assessment of WNV replication in HFF and Vero cells.
Immunohistochemistry assessment of the production of infectious progeny
virus from WNV-infected HFF cells (black bars) and Vero cells (stripped
bars) at 0, 6, 10, 24, and 48 h pi titrated on fresh vero cell cultures.Results
Human skin fibroblasts support productive WNV infection
To determine whether WNV could productively infect
primary human foreskin fibroblasts (HFF) cells, we com-
pared the growth kinetics of WNV in HFF cells and Veromonkey kidney epithelial cells. HFF and Vero cells were
infected for 1 h with a multiplicity of infection (moi) of 20
with Vero-cell-derived WNV, washed extensively, and cul-
tured in DMEM. Recoverable progeny virus present in the
supernatants of these cultures at 0, 6, 10, 24, and 48 h
postinfection (pi) was assessed by titrating the culture
supernatants on fresh, adherent Vero cell cultures using
immunohistochemistry (IHC). Infectious WNV was found
to be present in the supernatants of infected HFF cells by 6
h postinfection (pi), and at successively higher amounts by
10, 24, and 48 h pi (Fig. 1). Similarly, infectious WNV
was present in infected Vero cell supernatants by 6 h pi,
and at successively higher amounts by 10, 24, and 48
h postinfection (Fig. 1). Although infectious virus was
detectable both in infected HFF and vero culture super-
natants, higher amounts of WNV were detectable in vero
cells compared to HFF cells at 24 and 48 h pi. These data
indicate that both HFF and Vero cell lines are infectable
and support productive replication of WNV.
4G4-FLUOS specifically binds WNV-infected cells
The anti-nonstructural protein-1 (NS1) specific antibody,
4G4 immunoglobulin (4G4-Ig), has been demonstrated to
bind NS1 from a variety of different flaviruses (Hall,
unpublished observations). To confirm that 4G4 Ig was
specifically able to detect WNV NS1, HFF and Vero cells
were infected with WNV, or for control purposes, infected
with human cytomegalovirus (strain AD169, at an moi of 5),
then incubated with FLUOS-conjugated 4G4 Ig (4G4-
FLUOS) or control antibody MLF1-FLUOS for immuno-
fluorescence (IF) analysis, or incubated with rat poly-clonal
anti-WNV sera for immunohistochemistry (IHC) analysis.
WNV-infected HFF and vero cells were specifically
detected by 4G4-FLUOS in IF analysis and rat polyclonal
anti-WNV serum by IHC, but neither antibody stained
uninfected cells or cells infected with a completely different
virus, human cytomegalovirus (Figs. 2A and B, and data not
shown). Importantly, the same proportion of HFF or Vero
Fig. 2. Detection of WNV by immunohistochemistry and immunofluores-
cence. Microscopic analysis of WNV-infected (left-hand panels) or
uninfected (right-hand panels) (A) HFF cells or (B) Vero cells, 24 h pi.
Micrographs show (i) immunohistochemical detection of WNV proteins
with rat poly-clonal anti-WNV sera or (ii) immunofluorescence detection of
WNV NS1 protein with 4G4-FLUOS. Data shown are representative of
repeated experiments and virus infections at various moi.
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were stained with 4G4-FLUOS or with WNV-specific
polyclonal rat serum (Figs. 2A and B). Thus, 4G4-FLUOS
is useful for the specific detection of WNV-infected HFF
and Vero cells, and has a similar detection sensitivity to
conventional and well-established IHC-based methods us-
ing poly-clonal anti-WNV sera.
Cytokine-dependent upregulation of surface HLA in
WNV-infected HFF cells
Previous studies have demonstrated increased cell sur-
face expression of MHC (or HLA) after WNV infection on a
variety of mouse and human cell types, but not on cellsinfected with UV-inactivated virus (King et al., 1989; Shen
et al., 1997) (for reviews, see Kesson et al., 2002; Lobigs et
al., 1996). However, it is unknown whether this phenome-
non occurs in human cells that are physiologically relevant
to in vivo WNV infection, such as skin fibroblasts. Using
the newly generated 4G4-FLUOS and flow cytometry,
WNV-infected HFF cells were examined for alterations in
HLA expression using a pan-HLA-specific antibody W6/32.
Flow cytometry histograms demonstrate high endogenous
levels of HLA expression on HFF cells, but increased
surface levels of HLA on HFF cells infected with WNV
(Fig. 3A). WNV appeared to increase surface HLA expres-
sion to approximately the same extent as control HFF
cultures treated with rIFN-g, a cytokine with known ability
to increase MHC expression (Wong et al., 1983, 1984) (Fig.
3A). Thus, WNV infection increased surface HLA expres-
sion on HFF cells.
To determine whether only the WNV-infected cells had
increased surface HLA, two-color flow cytometry was per-
formed using 4G4-FLUOS in combination with W6/32 anti-
HLA antibody. This revealed that only approximately18–
20% of HFF cells were producing detectable WNV NS1
protein (4G4-FLUOS+, FL1+ cells) (Figs. 3B and C), but that
there was an increase in the mean fluorescence intensity
(MFI) for HLA staining on all cells in the infected cultures
(Fig. 3D, and Table 2). Thus, even the uninfected cells (4G4-
FLUOS negative cells) exhibited increased surface expres-
sion levels of HLA proteins (Figs. 3B and D, and Table 2).
That all HFF cells in the WNV-infected cultures showed
increased surface HLA expression, and not just the 4G4-
FLUOS+ cells, suggested that this phenomenon might be
mediated via secreted molecules, such as innate anti-viral
cytokines, and influencing both uninfected and infected
cells. To test this hypothesis, WNV-infected HFFs were
cultured in the presence or absence of neutralizing anti-
bodies specific to human innate cytokines, interferon (IFN)-
a and IFN-h (IFNa/h), or tumor necrosis factor-a (TNFa),
and again examined by two-color flow cytometry. Anti-
body-mediated neutralization of IFNa/h or TNFa, singly or
in combination, resulted in greater numbers of 4G4 (anti-
NS1)-positive cells (Fig. 3B), which is consistent with the
known anti-viral properties of these cytokines (Ruby et al.,
1997; Wong and Goeddel, 1986). However, neutralization
of IFNa/h significantly reduced surface HLA expression on
4G4+ (WNV-infected) cells to levels equivalent to uninfect-
ed HFF cells. Interestingly, the 4G4 (uninfected) cells in
these cultures exhibited higher surface HLA expression
levels than the 4G4+ infected cells (Figs. 3B, C, and D,
and Table 2). Neutralization of TNF-a alone had only
minimal effect on surface HLA levels on either 4G4+ or
4G4 cells (Fig. 3B, C, and D, and Table 2). Consistent with
this, neutralization of both IFNa/h and TNFa also had little
additional affect on surface HLA expression over that
observed in IFNa/h-neutralized cells (Figs. 3C and D, and
Table 2). Thus, in WNV-infected HFF cells, innate IFNs
potently induce HLA expression in WNV-infected HFF
Fig. 3. Flow cytometry analysis of HLA expression on WNV-infected HFF cells. (A) HLA-expression on control mock-infected (thick line), IFN-g-treated
(dotted line), and WNV-infected (thin line) HFF cells 48 h pi at an moi of 10. Isotype control antibody staining is also shown (shaded histogram). (B) Two-
color flow cytometry of HLA and WNV NS1 (4G4-FLUOS) on mock-infected and WNV-infected (moi = 10) HFF cells in the presence or absence of
neutralizing antibodies to IFN-a, IFN-h, and TNFa, either singly or in combination. The region gate is set to delineate the point where V1% of cells are 4G4-
FLUOS positive in uninfected cultures. (C) Histogram overlays of HLA expression on HFF cells (black unfilled histogram), compared to HFFs after WNV-
infection (colored line, unfilled histograms), and after gating on 4G4+ HFF cells (R1 region-gated, colored, filled histograms), or 4G4 cells (R2 region gated,
colored, filled histograms). Isotype control staining is also shown (grey-filled histograms). Data shown are representative of independently repeated
experiments. (D) Relative HLA surface levels of WNV-infected and -uninfected HFF cells after culture in neutralizing antibodies to IFN-a, IFN-h, and TNFa,
either singly or in combination. Data shown represent a summary of replicate analysis from one representative experiment. Means and SD were calculated from
the MFI of replicate analysis. Statistically significant differences between the HLA mean MFIs on uninfected HFF cells compared to IFNg-treated or WNV-
infected HFF cells are indicated (*P V 0.05). Statistically significant differences between WNV-infected and HFF-infected cultures incubated with neutralizing
antibodies specific to IFNa/h or TNFa are also indicated (**P V 0.05), as are differences between uninfected (4G4+) and uninfected (4G4) cells within these
cultures (^P = 0.05).
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culture. Hence, cytokines IFNa/h and TNFa are important
in controlling the extent of flavivirus replication in HFF
cells as well influencing surface HLA expression levels on
both infected and uninfected HFF cells.
WNV induced increased HLA-A, TAP, and LMP-2 mRNA
levels in HFF cells
Despite the demonstrated induction of cell surface HLA
expression on WNV-infected HFF cells and the ameliora-
tion of this effect by neutralizing antibodies to IFNa/h andTNFa, it remained unclear whether WNV infection influ-
enced HLA mRNA levels in HFF cells. Therefore, RT-
PCR was used to determine if WNV influenced HLA gene
expression at the mRNA level. Briefly, RT-PCR analysis
was performed on RNA obtained from uninfected HFF
cells, HFF cells mock-infected with supernatant from
uninfected Vero cells, or HFF cells infected with WNV
for 24 or 48 h. Results indicated that HLA-A-specific
mRNA was increased approximately 3-fold in WNV-
infected cells 48 h pi, compared to uninfected cells, as
indicated by densitometry quantitation relative to G3PDH
mRNA levels in each treatment group (Fig. 4A). As
Table 1
Primers for RT-PCR and real-time RT-PCR
(A) Primers for RT-PCR
G3PDH sense 5V-GGAGCCAAACGGGTCATCATCTC-3V
G3PDG anti-sense 5V-ATGCCTGCTTCACCACCTTCTTG-3V
HLA-A sense 5V-GACGACACGCAGTTCGTG-3V
HLA-A anti-sense 5V-CATGTCCGCCGCGGTCCAA-3V
TAP1 sense 5V-TCTCCTCTCTTGGGGAGATG-3V
TAP1 anti-sense 5V-GAGACATGATGTTACCTGTCTG-3V
LMP-2 sense 5V-GGCATTGTGATGGGTTCTGATTCC-3V
LMP-2 anti-sense 5V-AAGATGACTCGATGGTCCACACCG-3V
WNV envelope-A 5V-TGAAGCTCACAACGAGAAAA-3V
WNV envelope-B 5V-ATAAACCATTCTCGGTGAAC-3V
HLA-ABC01 5V-GATTCTCCCCAGACGCCGAG-3V
HLA-A01 5V-CCTGGGCACTGTCACTGCTT-3V
HLA-B01 5V-GGACAGCCAGACCAGCAACA-3V
HLA-C01 5V-TCAGAGCCCTGGGCACTGTT-3V
(B) Primers for real-time RT-PCR
G3PDH sense 5V-GGAGTCAACGGATTTGGTCGTA-3V
G3PDH anti-sense 5V-GCAACAATATCCACTTTACCAGAGTTAA-3V
HLA-A sense 5V-TGAGTGGGCCTTCACATTCC-3V
HLA-A anti-sense 5V-GGGCGCCGTGGATAGAG-3V
HLA-B sense 5V-TGCTGGTCTGGTCTCCACAA-3V
HLA-B anti-sense 5V-TCTACCCTGCGGAGATCACACT-3V
HLA-C sense 5V-GCTCGGTGTCCTGAGTTTGG-3V
HLA-C anti-sense 5V-GGCTTCTACCCTAGCGGAGATC-3V
TNFa sense 5V-CTTCTGCCTGCTGCACTTTG-3V
TNFa anti-sense 5V-GCCAGAGGGCTGATTAGAGAGA-3V
IFNh sense 5V-GACATCCCTGAGGAGATTAAGCA-3V
IFNh anti-sense 5V-GGAGCATCTCATAGATGGTCAATG-3V
Fig. 4. RT-PCR analysis of HLA-A and associated molecules, TAP-1 and
LMP-2, in WNV-infected HFF cells. RT-PCR gel electrophoresis and
densitometry analysis of HLA-A, TAP-1, LMP-2, WNV-envelope (E), and
G3PDH mRNA levels in (A) untreated (media), uninfected (mock), IFNg-
treated, or WNV-infected (moi = 10) HFF cells at 24 and 48 h pi, or (B)
WNV-infected HFF cells cultured in the presence or absence of neutralizing
antibodies to type-I IFNs and TNFa. Densitometry graphs show the relative
abundance (arbitrary units) of intensity of PCR cDNA normalized to levels
of G3PDH cDNA in the corresponding individual samples. Data were
generated with Scion Image software (Scion Corporation, Maryland, USA).
Data shown are representative of two repeated PCR reactions analyzed
during the linear phase of the PCR amplification and from independently
repeated experiments. PCR products were sequenced to verify PCR product
identity.
S.J. Arnold et al. / Virology 324 (2004) 286–296290expected, IFN-g, used as a positive control, also increased
the abundance of HLA-A mRNA to approximately the
same extent (Fig. 4A). We also assessed the levels of
mRNAs for the class I processing molecules transporter
associated with antigen processing (TAP-1) and low mo-
lecular weight polypeptide (LMP-2). RT-PCR analysis of
TAP-1 and LMP-2 also demonstrated that WNV infection
of HFF cell cultures results in increased mRNA for TAP1
and LMP-2 by 48 h pi (Fig. 4A). Thus, WNV infection
results in increased mRNA for HLA-A, TAP-1, and LMP-2
in HFF cell cultures.
Cytokine-dependent and -independent alterations in mRNA
expression
Because WNV-induced upregulation of surface HLA in
HFFs is influenced by innate cytokines, RT-PCR was also
performed in cells cultured in the presence of neutralizing
antibodies to these cytokines. However, neutralizing IFNa/hor TNFa, either singly or in combination, only minimally
affected mRNA levels of HLA-A inWNV-infected HFF cells
(Fig. 4B), implying a largely IFNa/h and TNFa-independent
mechanism for the increased HLA mRNA levels. In contrast,
WNV-induced TAP-1 mRNA was partially dependent on
IFNa/h and TNFa, because treatment with neutralizing anti-
bodies to these cytokines diminished the WNV-induced
expression of TAP-1 mRNA (Fig. 4B). Interestingly, neu-
tralizing TNFa slightly increased basal expression levels
HLA-A and LMP-2 mRNA (Fig. 4B). Neutralizing type-I
IFNs either alone or in combination with anti-TNFa also
increased WNV (E) protein expression, as expected (Fig.
4B). Thus, virus-induced IFNa/h only minimally contribut-
ed to the increased HLA, TAP1, and LMP-2 mRNA expres-
sion after WNV infection.
Real-time RT-PCR for HLA-A, -B, and -C mRNA
To confirm these RT-PCR results, to more accurately
quantitate the differences in mRNA levels, and to extend
the HLA analysis to other HLA-locus genes including
HLA-A, HLA-B, and HLA-C genes, we performed real-
time RT-PCR. Because the exact HLA haplotype of the
HFF donor cells was unknown, RT-PCR was first per-
formed using HLA-locus specific primers (Johnson, 2000;
see Table 1). Sequence analysis of these 1-kb HLA-A-,
-B-, and -C-specific PCR products was then used to
S.J. Arnold et al. / Virologydesign locus-specific primers for real-time quantitative
RT-PCR analysis (see Table 1). Real-time RT-PCR anal-
ysis of HLA-A confirmed the RT-PCR results shown in
Fig. 4, clearly indicating that WNV infection of HFF cells
leads to a 2-fold increase in mRNA for HLA-A by
24 h pi and a 4-fold increase by 48 h pi (Fig. 5A).
Furthermore, the real-time PCR analysis demonstrated
that WNV infection resulted in a 3-fold increase in
HLA-B and -C mRNAs by 24 h pi and up to 7-fold
increase in these mRNAs by 48 h pi (Fig. 5A). Hence,
WNV infection of HFF cells results in a significant
increase in mRNA levels of HLA-A, -B, and -C genes.
However, real-time RT-PCR analysis of HFF cultures
treated with IFNa/h- and TNFa-neutralizing antibodies
also demonstrated that IFNa/h had minimal effect on
WNV-induced alterations in HLA-A, -B, and -C mRNA
levels, although neutralization of TNFa caused a 1- to 2-
fold increase in mRNA for HLA-B and -C in WNV-
infected HFF cells (Fig. 5B). Thus, WNV infection
induces increased HLA-A, -B, and -C mRNAs through
a primarily IFNa/h-independent mechanism, and TNFa
surprisingly limits the increase in HLA mRNA levels in
infected HFF cells.Fig. 5. Real-time RT-PCR analysis of HLA-A, -B, and -C, IFNh, and TNFa in WN
in WNV-infected HFF cells cultures or IFNg-treated cultures 24 and 48 h pi. (B) A
presence or absence of neutralizing antibodies to type-I IFNs and TNFa, 24 h pi, as
with WNV. Levels of G3PDH mRNA are also shown, but are largely unaltered. Da
two repeated cDNA synthesis and PCR analysis from each experiment.WNV induces abundant IFNb and TNFa in HFF cells
Given that neutralization of IFNa/h or TNFa altered the
levels of detectable WNV NS1 (Fig. 3B), WNV E mRNA
(Fig. 3), and influenced surface HLA proteins (Fig. 3C) in
WNV-infected HFF cells, we sought to directly demonstrate
that these cytokines are produced by WNV-infected HFF
cells. Using real-time RT-PCR, large amounts of TNFa and
IFNh mRNAs were found in infected HFF cells by 24 h pi
(Fig. 5C). Hence, increased expression of IFNh and TNFa
mRNA correlated perfectly with results obtained using
IFNh- and TNFa-neutralizing antibodies.
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To date, few studies have examined flavivirus replication
in human cells that are physiologically relevant to in vivo
infection. We have studied flavivirus replication in human
skin fibroblast cells that are physiologically relevant to in
vivo infection, for example, via inoculation from a virus-
bearing tick or mosquito. The generation of a monoclonal
antibody, 4G4, specific to flavivirus-NS1 proteins, has al-V-infected HFF cells. (A) Analysis of mRNA levels of HLA-A, -B, and -C
nalysis of mRNA levels of the same molecules in HFF cells cultured in the
indicated. (C) Analysis of mRNA levels of IFNh and TNFa 24 and 48 h pi
ta shown are representative of two independently repeated experiments and
S.J. Arnold et al. / Virology 324 (2004) 286–296292lowed us to specifically detect WNV-infected cells at a single
cell level, with a comparable sensitivity to conventional
IHC staining with poly-clonal anti-WNV serum (Fig. 2).
The use of flow cytometry, together with 4G4-FLUOS and
neutralizing antibodies to IFNa/h and TNFa, has revealed
that WNV-induced surface HLA expression is critically
dependent on IFNa/h in HFF cells (Fig. 3). In fact, when
virus-induced IFNa/h is neutralized, WNV-infected cells
express levels of surface HLA that are equivalent to basal
HLA levels on uninfected HFF cells (Figs. 3C and D and
Table 2). Thus, innate IFNs produced by virus-infected
fibroblasts critically influence surface HLA expression in
both the infected and neighboring uninfected HFF cells.
Other factors, in addition to IFNa/h and TNFa, also appear
to contribute to WNV-induced HLA expression, because
neutralization of IFNa/h and TNFa failed to significantly
abrogate HLA-A, -B, and -C mRNA levels, which we
demonstrate are increased in WNV-infected HFF cell cul-
tures (Figs. 4 and 5). Thus, innate IFNs, which are induced
during flavivirus infection (Fig. 5 and Kurane et al., 1992),
critically influence the final biological outcome of WNV
infection in HFF cells both in terms of regulating virus
replication and controlling surface HLA expression. The
precise mechanisms by which innate interferons influence
surface HLA expression but only minimally alter HLA
mRNA levels are unknown. It is possible that posttranscrip-
tional events are important or that this reflects the actions of
IFNs on other molecules necessary for the generation of
antigenic peptide, their loading onto HLA, or trafficking of
HLA molecules. However, UV-inactivated WNV fails to
induce surface class I molecules in human or murine cells
(King et al., 1989; Shen et al., 1997), indicating that active
virus replication is required for increased surface HLA
expression in most cell types.Table 2
Intensity of HLA expression on WNV infected HFF cellsa
Treatmentb MFI-PEc (Anti-HLA)
Total WNV+ WNV
Control antibody 9 N/a N/a
Mock infection (media only) 1492 N/a 1492
rHuIFNg 2020 – –
WNV + media 2422 2550 2382
WNV + anti-IFNa/h 1535 1433 1864
WNV + anti-TNFa 2460 2914 2373
WNV + anti-IFNa/h + anti-TNFa 1688 1644 1857
a HFF cells (106 cells) were seeded overnight in 10-cm dishes and infected
with WNV for 48 h, then stained for detection of HLA surface expression.
Data shown are from one experiment, but are representative of three
experiments. N/a, not applicable; – , not done.
b Cells were grown in media only, media containing 10 Ag rHuIFNg or
media containing neutralizing antibody specific to HuIFNa/h, or HuTNFa,
or both antibodies, as indicated.
c Mean fluorescence intensity (MFI) for PE. WNV+ cells are defined as
those gated for 4G4-FLUOS+ fluorescence (Fig. 3C, region 1), and WNV-
values are gated on 4G4-FLUOS fluorescence (Fig. 3C, region 2).RT-PCR analysis also demonstrated that WNV infection
results in increased LMP-2 and TAP-1 mRNA levels in
infected HFF cultures. LMP-2 and TAP-1 molecules war-
ranted investigation because they are IFN-inducible and
because they both have considerable impact on antigen
processing and presentation, including influencing surface
levels of surface HLA expression (Chatterjee-Kishore et al.,
2000; Min et al., 1998). However, others have previously
reported increased TAP activity in WNV-infected HeLa and
LCL721 human cells without increased TAP mRNA or
protein (Momburg et al., 2001). These conflicting data
might be explained by the more sensitive comparative
densitometry and RT-PCR approach shown here, versus
immunoprecipitation and Western immunoblotting that are
significantly more difficult to accurately quantitate, and the
fact that macromolecular synthesis inhibitors cyclohexa-
mide and actinomycin D used by others have overwhelming
and catastrophic effects on host cells compared to neutral-
izing antibodies. Furthermore, these conflicting reports may
also simply reflect differences between HeLa cells and LCL
cells, compared to HFF cells, such as the amount of innate
IFNs produced upon infection, and further analysis is
required to address these possibilities. Nevertheless, it is
likely that both increased TAP-1 mRNA (Fig. 4) and TAP1
function (Momburg et al., 2001) result in increased peptide
supply into the endoplasmic reticulum, facilitating in-
creased surface HLA expression, given that other factors
within the class I pathways appear to remain functional
during flavivirus infection (Lobigs et al., 1996, 2003). The
fact that neutralizing antibodies to IFNa/h resulted in
different levels of surface HLA on 4G4+ cells compared
to 4G4 cells (Fig. 3D) is currently unexplained. It would
be highly desirable to perform RT-PCR analysis on 4G4+ or
4G4 FACS-sorted HFF cells and thereby determine the
relative levels of these mRNAs in infected versus uninfect-
ed HFF cells. This approach requires infection control
conditions that permit safe sorting of live, non-fixed,
WNV-infected primary human cells, which is currently
not available to us.
Paradoxically, the implied biological consequence of
increased HLA (and associated molecules TAP-1 and
LMP-2) is increased recognition of virus-infected cells by
MHC-restricted cytotoxic T cells (Douglas et al., 1994;
Momburg et al., 2001). However, this also affords in vitro
protection from NK cell cytotoxicity possibly implying an
important role for NK cells in flavivirus infection in vivo.
Nevertheless, it is currently unknown whether the docu-
mented alterations of MHC-I or HLA in flavivirus-infected
cells in vitro translate into any biological advantage or
disadvantage to the host individual. Perhaps the replication
of WNV in human skin is quickly replaced by infection of
neuronal cells where CD8+ T cell recognition becomes less
important. As such, WNV-induced surface HLA expression
might simply be a consequence of the vast amounts of
innate interferon-h and TNF-a, which are greatly increased
during flavivirus infection (Fig. 5), rather than being a
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via modulation of immune recognition molecules.
Finally, there is evidence that WNV-induced MHC
expression is partially dependent on the activation of NFnB
(Kesson and King, 2001; Kesson et al., 2002). Activation
of NFnB proteins might occur via protein kinase-R (PKR),
because flavivirus replication generates double-stranded
RNA intermediates and PKR is capable of activating
NFnB. Activation of NFnB may also occur via TNF-a
because TNF-a is also a known activator of NFnB (Hey-
ninck and Beyaert, 2001) and shown here to be induced by
WNV infection. In this regard, it is interesting to note that
human class I genes and the mouse H-2Kb gene 5V gene
promoter region contain distinct NFnB-transcription factor
binding sites (Proffitt et al., 1994), and the rat TAP-1 and
LMP-2 genes share a bidirectional promoter that includes
an interferon-stimulated response element (Georgopoulos et
al., 2000; Proffitt and Blair, 1997). Here, we have not
addressed the specific role of NFnB or other gene regula-
tory elements and transcription factors in mediating WNV-
induced HLA. Instead, we have focused on studying WNV
infection in cells that are physiologically relevant to pri-
mary human flavivirus infection, and demonstrated that
type-I IFNs and TNF-a are expressed in abundance in
WNV-infected human skin fibroblasts, and that WNV
infection results in increased surface HLA expression on
HFF cells via IFNa/h and TNFa-dependent and -indepen-
dent mechanisms.Materials and methods
Virus and cells
WNV (Sarafend strain) was a gift from A. Mullbacher
(John Curtin School of Medical Research, Australian Na-
tional University). High-titer virus stocks were prepared
from brain homogenates obtained from intracranially
WNV-infected neonatal mice, and used to infect Vero (Af-
rican green monkey kidney epithelial) cells to prepare a cell-
derived virus stock. Virus titers were estimated using rat
polyclonal sera and immunohistochemistry (IHC) staining,
as regularly used in our laboratory (Douglas et al., 1994) and
described below. Human cytomegalovirus (HCMV, strain
AD169) was obtained from the ATCC, and virus stocks
prepared in HFF human skin foreskin fibroblasts cells by
standard techniques. Vero cells were grown in DMEM with
5% heat-inactivated fetal bovine serum (FBS) at 37 jC with
5% CO2. Human foreskin fibroblast HFF cells were obtained
from Clonetics or from human donors, grown in DMEM
with 10% FBS, and cultured at 37 jC with 5% CO2.
Antibodies
Polyclonal anti-WNV-specific sera were obtained from
rats repeatedly infected with WNV. Control normal ratserum was obtained from Hunter Antisera (Jesmond, Aus-
tralia). 4G4-Ig is a newly derived monoclonal antibody with
specificity to flavivirus nonstructural protein-1 (NS1), and is
described elsewhere (Clarke et al., in preparation). Flavivi-
rus NS1 proteins are highly conserved within the Flavivirus
genus (Coia et al., 1988), and 4G4 antibody has been
demonstrated to bind to the NS1 proteins from a variety
of different flaviviruses, including yellow fever virus, den-
gue virus, Murray Valley encephalitis virus, Japanese en-
cephalitis virus, and WNV (Hall, personal communication).
Briefly, 4G4 Ig was purified from hybridoma culture super-
natants using a protein-A column, concentrated using a
Centricon-10 microcentrifuge device, isotyped as an IgG1
antibody using an ELISA assay (Harlow and Lane, 1988),
and conjugated to FLUOS using a fluorescein-labelling kit
(Roche Diagnostics, Germany). For control purposes, an
irrelevant IgG1 mouse antibody MLF-1 that has specificity
to murine FasL (Kayagaki et al., 1997) was also purified
from hybridoma cell supernatants and conjugated to
FLUOS. Human class I molecules were detected using the
antibody W6/32 that recognizes a variety of HLA proteins
(Ziegler et al., 1982). The following cytokine neutralizing
antibodies were also used: anti-human IFNa (sheep IgG),
anti-human IFNh (mouse IgG1, clone 76703.111 ), anti-
human TNFa (mouse IgG1, clone 28401.111 ) all from
R&D systems (Minneapolis, USA), or anti-human IFNh
purchased from Lee Biomolecular (San Diego, USA).
Virus growth kinetics
HFF and Vero cells were seeded into 24-well plates and
duplicate wells infected with WNV for 2 h at 37 jC. Cells
were washed three times after infection with 2 ml sterile
PBS and grown in 0.5 ml DMEM media containing 5%
FCS. At times 0, that is, immediately after infection, and 6,
10, 24, and 48 h postinfection (pi), the media were removed
and stored frozen at 20 jC. The presence of newly
produced progeny virus in these supernatants was assessed
24 h later by incubating duplicate100-Al aliquots of culture
supernatants on fresh Vero cell cultures grown overnight on
glass coverslips, and WNV detected by IHC staining with
rat polyclonal anti-WNV sera.
Immunohistochemistry staining for WNV
HFF and Vero cells were seeded into 24-well tissue
culture plates containing sterile 10-mm diameter glass cover
slips. Cells were infected for 1 h, then examined by IHC 24
h pi, as described previously (Douglas et al., 1994). Briefly,
cells were washed once with PBS, fixed with 1 ml cold
absolute ethanol for 20 min at 20 jC, and cover slips
stained in the 24-well plates. First, endogenous peroxidase
was blocked with 3% H2O2 in methanol for 10 min at room
temperature, then cells were incubated with 10% normal
goat serum for 30 min to block nonspecific binding. WNV
was detected with 100 Al of rat polyclonal anti-WNV sera
S.J. Arnold et al. / Virology 324 (2004) 286–296294described above (1:100 dilution), or for control purposes,
cells were also incubated with normal rat serum (1:100
dilution; Hunter Antiserum Australia) for 1 h at room
temperature, washed three times with Tris-buffered saline
for 5 min each, and incubated with 100 Al of biotinylated
anti-rat Ig (1:200 dilution; Selinus Laboratories, Hawthorne,
Australia) for 30 min at room temperature. After washing,
cells were exposed to ABC reagent (Vector Laboratories),
then DAB substrate-chromagen solution (Dako, Carpinteria,
CA, USA), washed again, counterstained in Harris’s Hema-
toxylin (BDH Laboratory supplies, Poole, UK) for 10 s,
differentiated in acid alcohol followed by blueing with
Scott’s Blue solution, and finally dehydrated through a
series of graded alcohols, cleared in xylene, and mounted
in DPX mounting medium (BDH Laboratory supplies).
Immunofluorescence detection of WNV
HFF and Vero cell cultures were stained for immunoflu-
orescence (IF) analysis. Briefly, cells were seeded onto glass
cover slips and stained 24 h post WNV infection. Cells were
fixed with 2% paraformaldehyde for 20 min at 4 jC, washed
twice with PBS, and blocked with PBS containing 2%
normal goat serum plus 2% normal rat serum, permeabilized
with 0.1% saponin in PBS, and incubated with 100 Al of
4G4-FLUOS (1:30 dilution), or control antibody MLF1-
FLUOS (also diluted 1:30) in 0.1% saponin PBS, for 1 h at
4 jC. Cells were again washed three times with 0.1%
saponin PBS, and finally with PBS, and cover slips were
mounted onto glass microscope slides with MicroTrak anti-
fade mounting medium (Syva; Behring Diagnostics Inc.,
Cupertine, CA, USA). IF and IHC slides were examined
using an Olympus AX70 microscope, and digital images
were captured using StudioLite software (ImmerVision,
version 1.0).
Flow cytometry
Subconfluent HFF cells were seeded overnight, infected
with WNV, washed, and then incubated for 48 h and
harvested for examination by flow cytometry. Because
HFF cells are adherent, cells were removed from tissue
culture dishes with 2 SSC before FACS staining, as
described previously (Sedger et al., 1999). Briefly, for single
color analysis, cells were blocked by incubating in PBS
containing 1% normal goat serum and 1% normal rat serum,
then incubated with the pan HLA-specific antibody W6/32
(Barnstable et al., 1978), washed with PBS containing 5%
heat-inactivated fetal calf serum, incubated with biotinylated
goat anti-mouse Ig (Jackson Laboratories), and finally with
streptavidin-PE (Pharmingen), fixed in 2% paraformalde-
hyde/PBS and analyzed. For two-color analysis, cells were
blocked, incubated with W6/32, biotinylated goat anti-
mouse Ig, and streptavidin-PE, as described for single color
analysis, then fixed with 2% paraformaldehyde/PBS, per-
meabilized with 0.1% saponin/PBS, and incubated with4G4-FLUOS or MLF1-FLUOS in 0.1% saponin/PBS buffer
for 1 h. Cells were washed three times in 0.1% saponin/PBS
to remove excess FLUOS Ig. For both single and two-color
flow cytometry analysis, a minimum of 10,000 events was
collected using a FASCalibur (Becton Dickenson, San Jose,
USA), and analyzed with Cell Quest system software
(Becton Dickenson). The mean fluorescence intensity
(MFI) of replicate analysis was summed and divided by
the number of analysis, generating a mean and SD for each
treatment group. This type of assessment of FACS histo-
grams was used to perform statistical analysis (Student’s t
test) of MFI data.
RT-PCR and real-time RT-PCR analysis
Total cellular RNA was prepared from infected or unin-
fected HFF cells cultured in 10-cm dishes. Briefly, RNAwas
prepared using RNeasy mini columns (Qiagen) and RNA
quantified by absorbance at 260 nm. First-strand cDNAwas
synthesized from 2 Ag of RNA using a cDNA synthesis kit
(Invitrogen, Life Technologies). RT-PCR was then per-
formed with the gene-specific primers listed in Table 1.
PCR products were resolved by electrophoresis on a 1%
TBE agarose gel and visualized by ethidium bromide
staining. All RT-PCR products were purified and sequenced
to confirm specific amplification of target cDNAs, cloned
into pGEM-T Easy vector (Promega), and used as positive
control cDNA templates in subsequent PCR analysis (data
not shown). HLA-A primers for RT-PCR were designed
from NCBI database sequences. Because HFF cells are from
human foreskin donors and the precise HLA haplotypes are
unknown, locus-specific PCR amplification of constant
regions of HLA-A, -B, and -C alleles was performed using
RT-PCR primers HLA-ABC01 and either HLA-A01, HLA-
B01, or HLA-C01 (see Table 1), as described previously
(Johnson, 2000). These 1-kb HLA PCR products were also
cloned into pGEM-T vectors, sequenced, and the nucleotide
sequence data were used to design primers for the real-time
RT-PCR amplification of 80- to 100-nt amplicons. All
primers for real-time RT-PCR were designed using Primer
Express software (Applied Biosystems), and are also shown
in Table 1. Real-time RT-PCR was performed using SYBR
Green mastermix (Applied Biosystems) according to the
manufacturers directions, an ABI Prism 7700 Sequence
Detector (Applied Biosystems), and analyzed using Se-
quence Detection Systems version 1.9.1 (ABI Prism, Ap-
plied Biosystems). First, real-time PCRs were performed to
optimize primer and template concentrations before analysis
of samples for the data shown; primers were used at 10 pM
per reaction, and cDNA diluted 1/20 for G3PDH and HLA
analysis, or 1/10 for IFNh and TNFa analysis. All RT-PCR
and real-time RT-PCR primers amplify DNA sequences that
span intron–exon junctions, except for HLA-A, -B, and -C
primers that, as mentioned above, are locus-specific rather
than gene-specific, and IFNh which is an intronless gene.
Amplicons for real-time PCR were checked for specificy by
S.J. Arnold et al. / Virology 324 (2004) 286–296 295BLAST analysis, and real-time PCR cDNA products were
electrophoresed on 4–20% TBE acrylamide gels stained
with ethidium bromide for visualization to confirm ampli-
fication of a single cDNA product.Acknowledgments
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